GleamWall
中文EN

BICX BioCorRx Inc.

Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1443863 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-78.9%
TTM net income YoY51.3%
TTM EPS YoY52.0%
Revenue 3-yr CAGR-10.2%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-3,921.4%
Net margin-1,837.6%
FCF margin—
EBITDA margin-4,007.3%

Returns

ROE—
ROA-43.8%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets826.2%
Debt / equity—
Current ratio0.06x
Interest coverage-30.03x

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$797,244$7,665
Cost of revenue—$1,667
Gross profit—$5,998
R&D expense$1.77M$1.48M
SG&A expense$3.79M$3.61M
Operating income-$4.83M-$5.12M
Interest expense$223,850$776,780
Pretax income-$3.51M-$5.21M
Income tax$0$0
Net income-$3.44M-$5.11M
EBITDA-$4.79M-$5.09M
EPS (diluted)-0.19-0.49
Weighted avg. shares (diluted)18.49M10.46M
Banking
Noninterest income—$105,978
Balance sheet
Cash & equivalents$139,360$88,033
Receivables$253,459$0
Inventory$143,425$0
Current assets$814,468$117,996
PP&E, net$4,062$18,977
Goodwill$563,158$0
Intangibles$564,460$7,848
Total assets$2.15M$385,941
Current liabilities$8.31M$8.21M
Short-term debt$0—
Total liabilities$13.67M$12.74M
Shareholders' equity-$11.22M-$12.12M
Shares outstanding24.49M13.30M
Cash flow statement
Operating cash flow-$2.30M-$1.10M
Financing cash flow$2.35M$1.12M
Depreciation & amortization$44,003$33,145
Stock-based compensation$592,604$1.22M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.